Adult Anaplastic Astrocytoma, Adult Anaplastic Ependymoma, Adult Anaplastic Oligodendroglioma, Adult Giant Cell Glioblastoma and Adult Glioblastoma Clinical Trial Using Temozolomide, hypofractionated radiation therapy, bevacizumab and questionnaire administration

- The folks at Northwestern University are studying the effects of Temozolomide; hypofractionated radiation therapy; bevacizumab; questionnaire administration on Adult Anaplastic Astrocytoma, Adult Anaplastic Ependymoma, Adult Anaplastic Oligodendroglioma, Adult Giant Cell Glioblastoma and Adult Glioblastoma in individuals ages 18 years and older. This clinical trial is slated to start November 2011 and is expected to end circa November 2014.

3126951301
Study Coordinator
Overall Study Contact Info
StatusName Contact Phone
RecruitingStudy Coordinatorcancertrials@northwestern.edu3126951301

This study is officially titled, "A Phase II Study of the Efficacy of Hypofractionated Radiation Therapy With Bevacizumab and Temozolomide Followed by Maintenance Temozolomide and Bevacizumab for Recurrent High-Grade Gliomas."

Locations

Northwestern University

Chicago, Illinois - Recruiting

University of Chicago

Chicago, Illinois - Recruiting

Northwestern Lake Forest Hospital

Lake Forest, Illinois - Recruiting

Edward Cancer Center

Naperville, Illinois - Recruiting

Central Dupage Hospital

Warrenville, Illinois - Recruiting

For more study details, please visit this link to ClinicalTrials.gov record, which is the source of this webpage.